Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lymphoma, T-Cell, Peripheral × Etoposide × Clear all

Phase

Phase 2 8 Phase 1 4 Phase NA 2 Phase 3 1 Phase 1/2 1

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Small Cell Lung Carcinoma 30 Leukemia 30 Lymphoma 27 Leukemia, Myeloid, Acute 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 23 Lung Neoplasms 21 Lymphoma, Large B-Cell, Diffuse 16 Lymphoma, Non-Hodgkin 12 Leukemia, Erythroblastic, Acute 12 Neuroblastoma 11 Leukemia, Myelomonocytic, Acute 11 Leukemia, Monocytic, Acute 11 Leukemia, Megakaryoblastic, Acute 11 Hodgkin Disease 11 Carcinoma, Non-Small-Cell Lung 10 Sarcoma 9 Lymphoma, Large-Cell, Immunoblastic 8 Lymphoma, Follicular 8 Burkitt Lymphoma 8 Testicular Neoplasms 6 Teratoma 6 Myelodysplastic Syndromes 6 Congenital Abnormalities 6 Endodermal Sinus Tumor 5 Central Nervous System Neoplasms 5 Anemia, Refractory, with Excess of Blasts 5 Testicular Germ Cell Tumor 4 Neuroectodermal Tumors, Primitive, Peripheral 4 Multiple Myeloma 4 Brain Neoplasms 4

Interventions

10-propargyl-10-deazaaminopterin 7 Vincristine 5 Prednisone 5 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 5 Cyclophosphamide 5 Doxorubicin 4 romidepsin 3 belinostat 3 Gemcitabine 3 liposomal doxorubicin 1 duvelisib 1 Vitamin B 12 1 MLN 8237 1 Folic Acid 1 Etoposide 1 E7777 fusion protein 1 Decitabine 1 Brentuximab Vedotin 1 Bendamustine Hydrochloride 1 BAEC protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07258680 2025-12-02

BrEto-TCL

N.N. Petrov National Medical Research Center of Oncology

Phase 3 Enrolling by invitation

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡